Tonix Pharma (TNXP) Tops Q3 EPS by 270c
Tweet
Share
E-mailGet Alerts TNXP Hot Sheet
Join SI Premium – FREE
Tonix Pharma (NASDAQ: TNXP) reported Q3 EPS of ($0.23), $2.70 better than the analyst estimate of ($2.93). Revenue for the quarter came in at $2.82 million versus the consensus estimate of $3.08 million.
For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- RBC Capital Reiterates Outperform Rating on Safran SA (SAF:FP) (SAFRF)
- American States Water completes $200 million ATM equity offering
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
